Open AccessA randomised, double‐blind, placebo‐controlled trial of gemeprost (Cervagem) pessaries for cervical dilatation in non‐pregnant women
Author(s) -
Elder M. G.,
Lewis G.
Publication year - 1991
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016349109006198
Subject(s) - medicine , pessary , placebo , cervical dilatation , cervix , incidence (geometry) , obstetrics , adverse effect , double blind , gynecology , physics , pathology , cancer , optics , alternative medicine
In a randomised, double‐blind trial, 75 women received either placebo or a 1‐mg gemeprost (Cervagem) pessary for cervical dilatation prior to gynecological procedures which require mechanical dilatation of the cervix. No significant difference was seen between gemeprost and placebo with respect to preoperative cervical dilatation. The incidence of vaginal bleeding and adverse effects was similar in each group.